Search For "glenmark pharmaceuticals"
Glenmark launches Tavulus® for COPD treatment in Spain
Updated : 4 days, 22 hours ago IST
Mumbai (Maharashtra) [India], October 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spa
Read More
Glenmark receives marketing approval for Ryaltris®, an innova
Updated : 2 weeks, 1 day ago IST
Mumbai (Maharashtra) [India], September 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris® in 13 countries across the EU and UK.
Read More
Glenmark receives marketing approval for Ryaltris in 13 countries
Updated : 2 weeks, 2 days ago IST
New Delhi [India] September 30 (ANI): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13 countries across the EU and UK.
Read More
Apposite wins the coveted Brandon Hall Group Silver Award for exce
Updated : 3 weeks, 3 days ago IST
Hyderabad (Telangana) [India], September 21 (ANI/BusinessWire India): Apposite Learning Solutions, a Hyderabad-based organization is renowned for creating innovative learning solutions for premier clients such as Microsoft, Coromandel, Glenmark Pharmaceuticals, among many others.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Ph
Updated : 3 weeks, 3 days ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
Glenmark concludes post marketing surveillance (PMS) study on Favi
Updated : 1 month ago IST
Mumbai (Maharashtra) [India], September 15 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India.
Read More
Glenmark's post-marketing surveillance shows no safety concerns on
Updated : 1 month ago IST
New Delhi [India], September 15 (ANI): The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection.
Read More
Glenmark Pharma reports revenue growth of 26% and PAT growth of 21
Updated : 2 months ago IST
Mumbai (Maharashtra) [India], August 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2021.
Read More
Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API busines
Updated : 2 months ago IST
Singapore, August 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient (API) business completed an initial public offering (IPO).
Read More
Glenmark, Canada's SaNOtize to commercialise nasal spray for Covid
Updated : 2 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], August 2 (ANI): Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research and Development Corp on Monday announced an exclusive long term strategic partnership to manufacture, market and distribute nitric oxide nasal spray (NONS) for Covid-19 treatmen
Read More
Glenmark to conduct phase III trials of nasal spray it claims to b
Updated : 3 months, 1 week ago IST
New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19.
Read More
Fitch affirms Glenmark Pharmaceuticals at BB with stable outlook
Updated : 3 months, 1 week ago IST
Singapore, July 6 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB with a stable outlook.
Read More